OrthoPediatrics shareholders elect directors, approve 2.05M share increase to incentive plan

Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows: For Against Abstain Broker Non-Votes 15,953,457 2,859,793 39,764 1,827,535

Approval, of an amendment to the 2024 Incentive Award Plan ("Plan") to increase the number of shares authorized under the Plan by 2,050,000 shares, which would increase the total number of shares to 3,679,000 The Company's stockholders approved the amendment to the 2024 Incentive Award Plan by voting as follows: For Against Abstain Broker Non-Votes 18,545,409 272,115 35,490 1,827,535

Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2026 The Company’s stockholders approved the appointment by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 by voting as follows: For Against Abstain 20,479,183 154,131 47,235

Election of Directors The nominees below were elected to serve as directors for a term that will last until the Company’s 2029 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows: Name Votes For Votes Withheld Broker Non-Votes George S. M. Dyer 10,843,747 8,009,267 1,827,535 Kelly Fischer 18,535,024 317,990 1,827,535 David R. Pelizzon 18,056,773 796,241 1,827,535 Harald Ruf 18,077,260 775,754 1,827,535